These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29396235)

  • 21. Diabetes, insulin use, and non-Hodgkin lymphoma mortality in Taiwan.
    Tseng CH
    Metabolism; 2012 Jul; 61(7):1003-9. PubMed ID: 22237115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark--a nationwide study.
    Frederiksen BL; Dalton SO; Osler M; Steding-Jessen M; de Nully Brown P
    Br J Cancer; 2012 Feb; 106(5):988-95. PubMed ID: 22315055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose Thiotepa, Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation as Upfront Consolidation for Systemic Non-Hodgkin Lymphoma With Synchronous Central Nervous System Involvement.
    Qualls D; Sullivan A; Li S; Brunner AM; Collier K; Hochberg E; Armand P; Batchelor TT; Chen YB; DeFilipp Z
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):884-888. PubMed ID: 28870642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barriers to inclusion of older adults in randomised controlled clinical trials on Non-Hodgkin's lymphoma: a systematic review.
    Bellera C; Praud D; Petit-Monéger A; McKelvie-Sebileau P; Soubeyran P; Mathoulin-Pélissier S
    Cancer Treat Rev; 2013 Nov; 39(7):812-7. PubMed ID: 23473865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03).
    Wirth A; Prince HM; Roos D; Gibson J; O'Brien P; Zannino D; Khodr B; Stone JM; Davis S; Hertzberg M
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1158-1166. PubMed ID: 30553941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast--a review of 42 primary and secondary cases in Taiwanese patients.
    Lin YC; Tsai CH; Wu JS; Huang CS; Kuo SH; Lin CW; Cheng AL
    Leuk Lymphoma; 2009 Jun; 50(6):918-24. PubMed ID: 19373599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E
    Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Statistical analysis of localized non-Hodgkin's lymphomas of the head and neck--multivariate analysis of prognostic factors and evaluation of therapeutic modalities].
    Tomita T; Fujii M; Imanishi Y; Kanke M; Kanzaki J; Ohno Y; Tokumaru Y; Inuyama Y
    Nihon Jibiinkoka Gakkai Kaiho; 1999 Jun; 102(6):809-17. PubMed ID: 10429435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow Transplantation.
    Truelove E; Fox C; Robinson S; Pearce R; Perry J; Kirkland K; McQuaker G; Pagliuca A; Johnson P; Russell N; Cook G;
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):483-8. PubMed ID: 25490180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network.
    Kane E; Howell D; Smith A; Crouch S; Burton C; Roman E; Patmore R
    Eur J Cancer; 2017 Jun; 78():53-60. PubMed ID: 28412589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-Hodgkin's lymphoma in Saskatchewan. A review of 10 years' experience.
    Maksymiuk AW; Bratvold JS; Ezzat W; Tan LK; Skinnider LF
    Cancer; 1994 Feb; 73(3):711-9. PubMed ID: 8299094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
    Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G;
    J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphoma.
    Osby E; Askling J; Landgren O; Dickman PW; Ekbom A; Björkholm M
    Acta Oncol; 2004; 43(3):297-301. PubMed ID: 15244255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study.
    Peters FP; Lalisang RI; Fickers MM; Erdkamp FL; Wils JA; Houben SG; Wals J; Schouten HC
    Ann Hematol; 2001 Mar; 80(3):155-9. PubMed ID: 11320900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma.
    Niitsu N; Iijima K; Chizuka A
    Eur J Haematol; 2001 Jan; 66(1):24-30. PubMed ID: 11168504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic importance of advanced age in aggressive non-Hodgkin's malignant lymphoma.
    Kovner F; Merimsky O; Inbar M; Soyfer V; Cahan Y; Rachmani R; Chaitchik S
    Oncology; 1996; 53(6):435-40. PubMed ID: 8960137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
    Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
    Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of hepatitis B virus infection and vaccination on the development of non-Hodgkin lymphoma.
    Huang CE; Yang YH; Chen YY; Chang JJ; Chen KJ; Lu CH; Lee KD; Chen PC; Chen CC
    J Viral Hepat; 2017 Oct; 24(10):885-894. PubMed ID: 28375587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating late adverse events using competing risks after autologous stem-cell transplantation in aggressive non-Hodgkin lymphoma patients.
    Ruiz-Soto R; Sergent G; Gisselbrecht C; Larghero J; Ertault M; Hennequin C; Manson J; de Kerviler E; Briere J; Mounier N
    Cancer; 2005 Dec; 104(12):2735-42. PubMed ID: 16284986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of geriatric assessment in combination with laboratory parameters in elderly patients with aggressive non-Hodgkin lymphoma.
    Aaldriks AA; Giltay EJ; Nortier JW; van der Geest LG; Tanis BC; Ypma P; le Cessie S; Maartense E
    Leuk Lymphoma; 2015 Apr; 56(4):927-35. PubMed ID: 24956143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.